![Steven Goldman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Steven Goldman
Sociétés | Poste | Début | Fin |
---|---|---|---|
Avery Therapeutics, Inc.
![]() Avery Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avery Therapeutics, Inc. engages in the development of tissue-engineered therapeutics to treat diseases and injuries to human muscle. Its product MyCardia™ is a tissue-engineered heart graft developed to treat heart failure. The company was founded by Steve Goldman and Jordan Lancaster in 2013 and is headquartered in Tucson, AZ. | Directeur Technique/Scientifique/R&D | 01/01/2013 | - |
Fondateur | 01/01/2013 | - |
Historique de carrière de Steven Goldman
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectorielle
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Avery Therapeutics, Inc.
![]() Avery Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avery Therapeutics, Inc. engages in the development of tissue-engineered therapeutics to treat diseases and injuries to human muscle. Its product MyCardia™ is a tissue-engineered heart graft developed to treat heart failure. The company was founded by Steve Goldman and Jordan Lancaster in 2013 and is headquartered in Tucson, AZ. | Commercial Services |
- Bourse
- Insiders
- Steven Goldman
- Expérience